Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA.
Med Phys. 2009 Oct;36(10):4359-69. doi: 10.1118/1.3213514.
Breast tumor volume measured on MRI has been used to assess response to neoadjuvant chemotherapy. However, accurate and reproducible delineation of breast lesions can be challenging, since the lesions may have complicated topological structures and heterogeneous intensity distributions. In this article, the authors present an advanced computerized method to semiautomatically segment tumor volumes on T1-weighted, contrast-enhanced breast MRI. The method starts with manual selection of a region of interest (ROI) that contains the lesion to be segmented in a single image, followed by automated separation of the lesion volume from its surrounding breast parenchyma by using a unique combination of the image processing techniques including Gaussian mixture modeling and a marker-controlled watershed transform. Explicitly, the Gaussian mixture modeling is applied to an intensity histogram of the pixels inside the ROI to distinguish the tumor class from other tissues. Based on the ROI and the intensity distribution of the tumor, internal and external markers are determined and the tumor contour is delineated using the marker-controlled watershed transform. To obtain the tumor volume, the segmented tumor in one slice is propagated to the adjacent slice to form an ROI in that slice. The marker-controlled watershed segmentation is then used again to obtain a tumor contour in the propagated slice. This procedure is terminated when there is no lesion in an adjacent slice. To reduce measurement variations possibly caused by the manual selection of the ROI, the segmentation result is refined based on an automatically determined ROI based on the segmented volume. The algorithm was applied to 13 patients with breast cancer, prospectively accrued prior to beginning neoadjuvant chemotherapy. Each patient had two MRI scans, a baseline MRI examination prior to commencing neoadjuvant chemotherapy and a 1 week follow-up after receiving the first dose of neoadjuvant chemotherapy. Blinded to the computer segmentation results, two experienced radiologists manually delineated all tumors independently. The computer results were then compared with the manually generated results using the volume overlap ratio, defined as the intersection of the computer- and radiologist-generated tumor volumes divided by the union of the two. The algorithm reached overall overlap ratios of 62.6% +/- 9.1% and 61.0% +/- 11.3% in comparison to the two manual segmentation results, respectively. The overall overlap ratio between the two radiologists' manual segmentations was 64.3% +/- 10.4%. Preliminary results suggest that the proposed algorithm is a promising method for assisting in tumor volume measurement in contrast-enhanced breast MRI.
磁共振成像(MRI)上测量的乳腺肿瘤体积已被用于评估新辅助化疗的疗效。然而,由于病变可能具有复杂的拓扑结构和不均匀的强度分布,因此准确且可重复地勾画乳腺病变具有一定的挑战性。在本文中,作者提出了一种先进的计算机方法,用于半自动分割 T1 加权对比增强乳腺 MRI 上的肿瘤体积。该方法首先手动选择包含要分割的病变的感兴趣区域(ROI),然后通过使用包括高斯混合建模和标记控制分水岭变换在内的独特图像处理技术组合,自动将病变体积与周围乳腺实质分离。具体而言,高斯混合建模应用于 ROI 内像素的强度直方图,以区分肿瘤类别与其他组织。基于 ROI 和肿瘤的强度分布,确定内部和外部标记,并使用标记控制分水岭变换描绘肿瘤轮廓。为了获得肿瘤体积,将一个切片中的分割肿瘤传播到相邻切片中,以在该切片中形成 ROI。然后再次使用标记控制分水岭分割在传播的切片中获得肿瘤轮廓。当相邻切片中没有病变时,该过程结束。为了减少可能由 ROI 的手动选择引起的测量变化,根据基于分割体积的自动确定的 ROI 对分割结果进行细化。该算法应用于 13 例乳腺癌患者,在开始新辅助化疗前前瞻性地进行 MRI 检查。每位患者均进行两次 MRI 扫描,在开始新辅助化疗前进行基线 MRI 检查,在接受新辅助化疗第一剂后 1 周进行随访。两名经验丰富的放射科医生对所有肿瘤进行独立手动勾画,对计算机分割结果进行盲法评估。然后使用体积重叠比将计算机结果与手动生成的结果进行比较,定义为计算机和放射科医生生成的肿瘤体积的交集除以两者的并集。与两名放射科医生的手动分割结果相比,该算法的总体重叠率分别为 62.6% +/- 9.1%和 61.0% +/- 11.3%。两名放射科医生手动分割的总体重叠率为 64.3% +/- 10.4%。初步结果表明,该算法是一种很有前途的方法,可用于协助对比增强乳腺 MRI 中的肿瘤体积测量。
J Magn Reson Imaging. 2010-7
J Med Signals Sens. 2021-12-28
J Digit Imaging. 2019-6
Contrast Media Mol Imaging. 2018-10-24
Med Phys. 2018-4-1
J Med Signals Sens. 2011-7
J Med Signals Sens. 2011-5
J Digit Imaging. 2011-10
IEEE Trans Image Process. 1993
CA Cancer J Clin. 2008
IEEE Trans Image Process. 1998
IEEE Trans Image Process. 1998
IEEE Trans Med Imaging. 1991
Med Phys. 2007-11
Radiol Clin North Am. 2007-9
Eur J Nucl Med Mol Imaging. 2007-12